MedPath

Evaluation of quantitative analysis of liver fibrosis by IVIM-DWI and Fibroscan in chronic liver disease.

Not Applicable
Conditions
chronic liverdisease
Registration Number
JPRN-UMIN000040636
Lead Sponsor
Juntendo University
Brief Summary

A weak correlation was observed between fibroscan and liver fibrosis markers and F IVIM, D*, suggesting that gender may be a confounding factor. IVIM-DWI alone should not be used as an index of liver cirrhosis, but should be comprehensively evaluated with other fibrosis markers and fibroscan.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
26
Inclusion Criteria

Not provided

Exclusion Criteria

1.Those who noticeably deteriorated image quality due to physical movement during the process. 2.Those who discontinue the test due to claustrophobia. 3.Those who refuse to participate due to disclosure of research information. 4.Those who the research director judges to be inappropriate as a research target.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To confirm the advantages of IVIM-DWI quantitative evaluation compared with Fibroscan
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath